van den Broek Richard
Transaction: 06/11/2026
BUY
Change
+15,000
Price
$11.60
Filing
06/15/2026
Type
BUY
Corvus Pharmaceuticals, Inc.
CRVS • Biotechnology
$10.23
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$944.92M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 6.21Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$10.23
Change0.00%
Shares Out92.37M
Market Cap$944.92M
Enterprise Value$730.42M
52W Range4.05 - 26.95
Beta0.82
P/E-17.46
P/B4.19
P/FCF-16.97
EV/EBITDA-13.43
EV/FCF-13.12
Price$10.23
Change0.00%
Shares Out92.37M
Market Cap$944.92M
Enterprise Value$730.42M
52W Range4.05 - 26.95
Beta0.82
P/E-17.46
P/B4.19
P/FCF-16.97
EV/EBITDA-13.43
EV/FCF-13.12
Earnings Yield-5.73%
FCF Yield-5.89%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio6.21
Quick Ratio6.21
Target$40.00
Target Upside291.01%
Target Median$40.00
Target Range40.00 - 40.00
Volume577.43K
Avg Volume1.48M
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
21/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 6.21Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$40.00
Mean
$40.00
Median
$40.00
High
$40.00
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Thompson Peter A.
Transaction: 06/11/2026
BUY
Change
+15,000
Price
$11.60
Filing
06/15/2026
Type
BUY
Grais Linda
Transaction: 06/11/2026
BUY
Change
+15,000
Price
$11.60
Filing
06/15/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| van den Broek Richard | BUY | +15,000 | $11.60 | 06/11/2026 | 06/15/2026 |
| Thompson Peter A. | BUY | +15,000 | $11.60 | 06/11/2026 | 06/15/2026 |
| Grais Linda | BUY | +15,000 | $11.60 | 06/11/2026 | 06/15/2026 |
| CLARK IAN T | BUY | +15,000 | $11.60 | 06/11/2026 | 06/15/2026 |
| Moore David Scott | BUY | +15,000 | $11.60 | 06/11/2026 | 06/15/2026 |
| Moore David Scott | BUY | +21,700 | $11.53 | 06/11/2026 | 06/15/2026 |
| MILLER RICHARD A MD | BUY | +5,000 | $12.05 | 05/18/2026 | 05/20/2026 |
| Chan Andrew C. | OTHER | 0 | Not reported | 04/23/2026 | 04/27/2026 |
| Chan Andrew C. | BUY | +30,000 | $16.02 | 04/23/2026 | 04/27/2026 |
| Thompson Peter A. | SELL | -15,000 | $3.27 | 01/28/2026 | 01/30/2026 |
| Thompson Peter A. | BUY | +30,000 | $15.00 | 01/28/2026 | 01/30/2026 |
| LEA LEIV | BUY | +400,000 | $8.81 | 12/04/2025 | 12/08/2025 |
| Arcara Jeffrey | BUY | +100,000 | $8.81 | 12/04/2025 | 12/08/2025 |
| MILLER RICHARD A MD | BUY | +1,000,000 | $8.81 | 12/04/2025 | 12/08/2025 |
| Jones William Benton | BUY | +400,000 | $8.81 | 12/04/2025 | 12/08/2025 |
| Moore David Scott | OTHER | 0 | Not reported | 10/02/2025 | 10/06/2025 |
| Moore David Scott | BUY | +30,000 | $7.04 | 10/02/2025 | 10/06/2025 |
| Thompson Peter A. | SELL | -1,397,684 | $3.50 | 06/27/2025 | 07/01/2025 |
| Thompson Peter A. | SELL | -1,176,332 | $4.16 | 06/27/2025 | 07/01/2025 |
| ORBIMED ADVISORS LLC | SELL | -1,397,684 | $3.50 | 06/27/2025 | 07/01/2025 |